IR
BSX icon

Invictus RG’s Boston Scientific BSX Stock Holding History

Invictus RG’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-14,798
Closed -$368K – 649
2017
Q1 		$368K Buy
14,798
+14,225
+2,483% +$346K 0.25% 140
2016
Q4 		$12K Buy
+573
New +$12.5K 0.01% 596
2016
Q1 		– Sell
-304
Closed -$6K – 600
2015
Q4 		$6K Buy
+304
New +$5.45K 0.01% 538

Other funds holding BSX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Invictus RG's BSX Position: Q2 2017 in Review

Invictus RG sold out of Boston Scientific (BSX) in Q2 2017, closing a stake of 14,798 shares — an estimated $368K sold.

Invictus RG first reported a position in BSX in Q4 2015 and held it in 3 quarters. The position peaked at $368K in Q1 2017. 558 funds tracked by Wall St. Rank hold BSX as of Q2 2017.

  • Invictus RG reported no remaining Boston Scientific position as of Q2 2017 after selling out during the quarter.
  • Invictus RG sold 14,798 Boston Scientific shares in Q2 2017, an estimated $368K.
  • Invictus RG first reported a position in Boston Scientific in Q4 2015 and held it in 3 quarters.
  • Invictus RG's Boston Scientific position peaked at $368K in Q1 2017.
  • 558 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2017.

Based on Invictus RG's 13F filing for Q2 2017, filed 14 Aug 2017.